Psychotherapy for Depression
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude participants who take more than 20 mg of benzodiazepines daily. It's best to discuss your specific medications with the study team.
What data supports the effectiveness of the treatment Behavioral Activation for depression?
Is psychotherapy for depression, including Behavioral Activation and similar therapies, generally safe for humans?
The research articles provided do not contain specific safety data for psychotherapy treatments like Behavioral Activation or similar therapies for depression. However, they discuss the importance of risk assessment and safety models in behavior analysis, which suggests that safety is a considered aspect in the field.678910
How is Behavioral Activation different from other treatments for depression?
Behavioral Activation (BA) is unique because it focuses on helping people engage in activities that bring them pleasure or a sense of achievement, which can improve mood and motivation. Unlike some therapies that require extensive psychological training, BA can be delivered by practitioners with less training, making it accessible in low-resource settings.15111213
What is the purpose of this trial?
The goal of this study is to learn the extent to which client-therapist brain activity may synchronize during a psychosocial intervention for depression symptoms.The study will compare behavioral activation, a client-centered type of cognitive-behavioral therapy, to psychoeducation which delivers information on strategies to recover from depression symptoms.Participants will answer questions about their mental and physical health, attend one psychosocial intervention session receiving either Behavioral Activation or Psychoeducation with simultaneous brain activity measurement and complete follow up surveys two weeks and one month following the intervention.
Research Team
Flavio Frohlich
Principal Investigator
Carolina Center for Neurostimulation
Eligibility Criteria
This trial is for individuals experiencing stress, depression, or anxiety. Participants should be willing to discuss their mental and physical health, attend a therapy session where their brain activity will be measured, and complete follow-up surveys.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants attend a single 60-minute psychosocial intervention session receiving either Behavioral Activation or Psychoeducation with simultaneous brain activity measurement
Follow-up
Participants complete follow-up surveys to assess changes in depression symptoms and therapeutic alliance
Treatment Details
Interventions
- Behavioral Activation
- Psychoeducation
Behavioral Activation is already approved in United States, China, European Union for the following indications:
- Depression
- Anxiety in older adults undergoing cardiac procedures
- Loneliness in older adults
- Depression
- Depression
- Anxiety
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Foundation of Hope, North Carolina
Collaborator